Wells Fargo & Company MN lowered its position in Masimo Corporation (NASDAQ:MASI) by 4.7% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 154,159 shares of the medical equipment provider’s stock after selling 7,617 shares during the quarter. Wells Fargo & Company MN owned approximately 0.30% of Masimo Corporation worth $14,055,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of the stock. BlackRock Inc. lifted its stake in Masimo Corporation by 4,676.3% in the first quarter. BlackRock Inc. now owns 7,364,235 shares of the medical equipment provider’s stock worth $686,789,000 after acquiring an additional 7,210,051 shares during the last quarter. Vanguard Group Inc. lifted its stake in Masimo Corporation by 5.9% in the first quarter. Vanguard Group Inc. now owns 4,617,633 shares of the medical equipment provider’s stock worth $430,641,000 after acquiring an additional 258,719 shares during the last quarter. Acadian Asset Management LLC lifted its stake in Masimo Corporation by 28.0% in the second quarter. Acadian Asset Management LLC now owns 1,791,597 shares of the medical equipment provider’s stock worth $163,356,000 after acquiring an additional 392,410 shares during the last quarter. State Street Corp lifted its stake in Masimo Corporation by 42.8% in the first quarter. State Street Corp now owns 1,401,516 shares of the medical equipment provider’s stock worth $130,704,000 after acquiring an additional 419,767 shares during the last quarter. Finally, Robeco Institutional Asset Management B.V. lifted its stake in Masimo Corporation by 27.1% in the second quarter. Robeco Institutional Asset Management B.V. now owns 1,095,353 shares of the medical equipment provider’s stock worth $99,872,000 after acquiring an additional 233,412 shares during the last quarter. Institutional investors own 83.21% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Wells Fargo & Company MN Sells 7,617 Shares of Masimo Corporation (MASI)” was originally reported by Watch List News and is the sole property of of Watch List News. If you are viewing this article on another website, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The legal version of this article can be accessed at https://www.watchlistnews.com/wells-fargo-company-mn-sells-7617-shares-of-masimo-corporation-masi/1600264.html.

In other news, insider Jon Coleman sold 25,000 shares of the stock in a transaction that occurred on Thursday, July 20th. The stock was sold at an average price of $97.50, for a total transaction of $2,437,500.00. Following the completion of the transaction, the insider now directly owns 32,201 shares in the company, valued at approximately $3,139,597.50. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Sanford Fitch sold 6,000 shares of the stock in a transaction that occurred on Thursday, July 13th. The shares were sold at an average price of $91.89, for a total value of $551,340.00. Following the transaction, the director now owns 89,249 shares of the company’s stock, valued at $8,201,090.61. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 112,000 shares of company stock valued at $10,444,090. Company insiders own 16.60% of the company’s stock.

Shares of Masimo Corporation (NASDAQ MASI) opened at 86.56 on Friday. The stock has a market cap of $4.50 billion, a P/E ratio of 14.19 and a beta of 0.84. Masimo Corporation has a 12 month low of $53.78 and a 12 month high of $104.71. The stock’s 50 day moving average is $85.78 and its 200 day moving average is $90.95.

Masimo Corporation (NASDAQ:MASI) last issued its quarterly earnings data on Wednesday, August 2nd. The medical equipment provider reported $0.83 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.71 by $0.12. Masimo Corporation had a net margin of 45.90% and a return on equity of 23.45%. The company had revenue of $192.90 million during the quarter, compared to the consensus estimate of $189.03 million. During the same quarter last year, the company earned $0.57 earnings per share. Masimo Corporation’s revenue for the quarter was up 11.8% on a year-over-year basis. Analysts predict that Masimo Corporation will post $2.80 earnings per share for the current fiscal year.

A number of brokerages recently issued reports on MASI. BTIG Research upgraded shares of Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 price target for the company in a research note on Monday, August 14th. BidaskClub downgraded shares of Masimo Corporation from a “hold” rating to a “sell” rating in a research note on Wednesday, August 9th. Stifel Nicolaus reiterated a “buy” rating and issued a $108.00 price target (up previously from $105.00) on shares of Masimo Corporation in a research note on Thursday, August 3rd. Roth Capital lifted their price target on shares of Masimo Corporation from $96.00 to $105.00 and gave the stock a “buy” rating in a research note on Wednesday, July 19th. Finally, Zacks Investment Research upgraded shares of Masimo Corporation from a “sell” rating to a “hold” rating in a research note on Tuesday, July 11th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and four have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $95.00.

About Masimo Corporation

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Institutional Ownership by Quarter for Masimo Corporation (NASDAQ:MASI)

Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.